Home CollegesCollege of Dentistry College of Medicine College of Nursing College of Pharmacy College of Public Health and Health Professions College of Veterinary Medicine HSC Jacksonville Campus InstitutesUF Health Cancer Center Clinical and Translational Science Institute Emerging Pathogens Institute Genetics Institute Institute on Aging McKnight Brain Institute UF Diabetes Institute Institute for Child Health Policy Shands PodcastsAnimal Airwaves Health in a Heartbeat About For MediaFacility Names HIPAA Guidelines Join Media List Leadership Biographies Media Experts Guide Patient Condition Reports Photo Library ContactMaking the Rounds Category: Department of Pharmaceutical Outcomes and Policy Recent Articles UF study finds FDA strategy cuts fetal exposure to harmful immunosuppressive drug, but risks remain By Matthew Splett • Nov 6, 2019 UF Health researchers receive NIH grants to help combat the opioid crisis By Diana Tonnesseen • Oct 1, 2019 Board of Governors selects UF to lead medical marijuana research consortium By Matthew Splett • Jun 14, 2019 New machine-learning model found effective at predicting risk of opioid overdose By Matthew Splett • Mar 26, 2019 New hepatitis C therapy effective, costs less for patients and payers, UF researchers find By Meghan Meyer • Feb 21, 2019 UF College of Pharmacy researchers secure $1.5 million grant to study hormonal contraceptive drug interactions By Donovan Baltich • Apr 23, 2018 Risk-sharing contracts could limit rising U.S. drug costs By Matthew Splett • Jan 30, 2018 Human liver protein reduces age-related inflammation in animal, human cell models By Doug Bennett • Nov 8, 2017 UF study raises questions about overmedicating young children diagnosed with ADHD By Matthew Splett • Aug 7, 2017 As competition goes down, generic drug prices rise, study finds By Matthew Splett • Jul 5, 2017 Pages1 2 next › last »